It is weird being on a board without a de-ramper that is for sure. I do miss the second guessing and reevaluating my position, after reading comments. Then again you go on other BB's and you hope for keyboard failure on mass. Careful what you wish for I guess :D.
I have to say now proactive investors is chasing for an interview. If Markku is still camera shy after this week I am investing a bit every few days. All the RNS have been quite dry and very specific. Carefully avoiding joining any dots to the overall picture. No feedback on Traumakine even with two studies feeding back very good results. Markku really explains things well, and is brimming with excitement in previous videos. He has stayed well away from interviews so far. This is starting to perk my interest! GLA.
Nothing like a court case to bring in the money that 'ALWAYS' works out well. This share is turning into a full on Dallas episode, all intrigue and no focus on what goes on at the oil field. I am out for a bit until the focus is back on .... pumping oil!
RE: Support Still Strong But Not Pleased12 Jul 2019 21:49
The BoD could really do with a decent Project Manger just focused on getting the wells operational. Would we be pumping oil by now, on the 'worst' deal available?
I guess the ii's are wanting to see trials ready to proceed before re-investing. Was Faron looking at funding Traumakine without a Partner? (one of the proactive interviews). Traumakine going to trial would defo have an effect on the SP :). Once they stop the INFORAAA study its game on IMO. Partner talk H2 that could from now till past Christmas. I would rather it was next week but that is the timescale.
I guess the ii's are wanting to see trials ready to proceed before re-investing. Was Faron was looking at funding Traumakine without a Partner (one of the proactive interviews). Traumakine going to trial would defo have an effect on the SP :).Once they stop the INFORAAA study its game on IMO.
Wonder if well see a TR-1. I saw a share get ground down 40%, triggered more than just stop losses over a month. Magically a Director bought a few million quids worth. Cheeky boy.
Sold half, ready to average down. SP could of stabilized if Traumakine situation was updated (badly worded RNS). Maybe the CEO wants to get the final results in. Anyone know when the INFORAAA study ends or is it rolling?